Tumour necrosis factor α regulates the miR‐27a‐3p–Sfrp1 axis in a mouse model of osteoporosis
Experimental Physiology · 2024-07 · 109 (7) · 1109-1123
DOI: 10.1113/ep090311 ↗At a glance
Journal article in Experimental Physiology, published online on 2024-05-15. Written by Dang-Feng Zhang and 6 co-authors. Institution: Department of Orthopedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Major MEDLINE topics: MicroRNAs, Osteoporosis, Tumor Necrosis Factor-alpha, Osteogenesis. Cited 9 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY 4.0). Funded by: Shaanxi Natural Science Basic Research Project.
Abstract (original language)
Osteoporosis is a metabolic bone disease that involves gradual loss of bone density and mass, thus resulting in increased fragility and risk of fracture. Inflammatory cytokines, such as tumour necrosis factor α (TNF‐α), inhibit osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs), and several microRNAs are implicated in osteoporosis development. This study aimed to explore the correlation between TNF‐α treatment and miR‐27a‐3p expression in BMSC osteogenesis and further understand their roles in osteoporosis. An osteoporosis animal model was established using ovariectomized (OVX) mice. Compared with Sham mice, the OVX mice had a significantly elevated level of serum TNF‐α and decreased level of bone miR‐27a‐3p, and in vitro TNF‐α treatment inhibited miR‐27a‐3p expression in BMSCs. In addition, miR‐27a‐3p promoted osteogenic differentiation of mouse BMSCs in vitro, as evidenced by alkaline phosphatase staining and Alizarin Red‐S staining, as well as enhanced expression of the osteogenic markers Runx2 and Osterix. Subsequent bioinformatics analysis combined with experimental validation identified secreted frizzled‐related protein 1 (Sfrp1) as a downstream target of miR‐27a‐3p. Sfrp1 overexpression significantly inhibited the osteogenic differentiation of BMSCs in vitro and additional TNF‐α treatment augmented this inhibition. Moreover, Sfrp1 overexpression abrogated the promotive effect of miR‐27a‐3p on the osteogenic differentiation of BMSCs. Furthermore, the miR‐27a‐3p–Sfrp1 axis was found to exert its regulatory function in BMSC osteogenic differentiation via regulating Wnt3a–β‐catenin signalling. In summary, this study revealed that TNF‐α regulated a novel miR‐27a‐3p–Sfrp1 axis in osteogenic differentiation of BMSCs. The data provide new insights into the development of novel therapeutic strategies for osteoporosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Orthopedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Nursing, Xi'an International University, Xi'an, Shaanxi, China.
ORCID profiles: Dang-Feng Zhang
Funding
- Shaanxi Natural Science Basic Research Project
Cite
APA
Zhang, D. F., Jin, X. N., Ma, X., Qiu, Y. S., Ma, W., Dai, X., & Zhang, Z. (2024). Tumour necrosis factor α regulates the miR‐27a‐3p–Sfrp1 axis in a mouse model of osteoporosis. Experimental Physiology, 109(7), 1109-1123. https://doi.org/10.1113/ep090311
Vancouver
Zhang DF, Jin XN, Ma X, Qiu YS, Ma W, Dai X, et al. Tumour necrosis factor α regulates the miR‐27a‐3p–Sfrp1 axis in a mouse model of osteoporosis. Experimental Physiology. 2024;109(7):1109-1123. doi:10.1113/ep090311
BibTeX
@article{Zhang2024,
author = {Zhang, Dang-Feng and Jin, Xiao-Na and Ma, Xing and Qiu, Yu-Sheng and Ma, Wei and Dai, Xing and Zhang, Zhi},
title = {Tumour necrosis factor α regulates the miR‐27a‐3p–Sfrp1 axis in a mouse model of osteoporosis},
journal = {Experimental Physiology},
year = {2024},
volume = {109},
number = {7},
pages = {1109--1123},
doi = {10.1113/ep090311}
}
EUVIMED